Study S002661

Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney Disease

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT03921242
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 4888
Start: 2019-08-01
Primary completion: 2023-08-01
Lead sponsor: Weill Medical College of Cornell University
Conditions: Diabetes Mellitus, Type 2; Renal Insufficiency, Chronic
Interventions: DRUG:Metformin; DRUG:Sulfonylurea; DRUG:DPP-4 inhibitor; DRUG:SGLT2 inhibitor; DRUG:GLP1 receptor agonist
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Incidence of Severe Hypoglycemia Assessed from EMR [18 Months]
Difference in Glycosylated Hemoglobin (HbA1c) level (mmol/mol) [24 Months]
Heterogeneity of Treatment Effect Via Pre-specified Sub-Group Analyses [25 Months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.